
Vaccine, Immunology, and Infectious Disease
Proven Experience Across Key Disease Areas
Our global and regional clinical trial experiences include a wide range of vaccine development, infectious disease and immunological studies, including but not limited to:
-
Dengue fever drug
-
COVID-19 vaccines and drug
-
Malaria drug
-
Human Papilloma Virus (HPV) vaccine
-
Human Immunodeficiency Virus (HIV) drug
-
Tuberculosis (TB) drug
-
Rotavirus vaccine
-
Leprosy drug
-
Hepatitis B vaccine
-
Hexavalent vaccine
Ready to discuss your next clinical research in Indonesia? Contact us today to learn how our expertise can accelerate your research in vaccines, immunology, or infectious diseases.
Our Impacts in Numbers

60+
Clinical trials site.

50,000+
Participants enrolled.

35+
Global and regional trials successfully managed.
Comprehensive Solutions for Your Trial Success
Our end-to-end services are designed to streamline your clinical trial process and mitigate risk:
-
Strategic Site Selection
We identify and qualify the most suitable Principal Investigators (PIs) from our network and high-performing sites, ensuring rapid patient enrollment. Our strong, long-term relationships with these sites enable a rapid start-up and predictable execution for your study. Click here to see our success story.
-
Regulatory Submissions and Compliance
Our experts manage all submissions to Ethics Committees (EC) and BPOM, navigating the local regulatory landscape to secure approvals efficiently. We have a strong relationship with BPOM and the Ministry of Health (MoH), and a deep understanding of the unique regulatory requirements for vaccine trials.
We are proud that our sites have successfully undergone inspections by international authorities such as BPOM, PMDA (Japan), and NMPA (China), a testament to our commitment to global quality standards.
-
Proactive Clinical Monitoring
Equilab's experienced Clinical Research Associates (CRAs) conduct rigorous monitoring to maintain data integrity and adherence to regulatory standards from site initiation, interim monitoring, until site closeout.
-
Pharmacovigilance
We implement a comprehensive safety monitoring system to manage adverse events swiftly and accurately, protecting patient welfare and your data.
-
Investigational Product (IP) and Sample Management
As your Importer of Record (IoR), Equilab simplifies the complex logistics of importing your Investigational Product (IP) into Indonesia. We provide secure depot facilities with strict temperature control for IP storage and distribution. Additionally, our central laboratory offers state-of-the-art biomedical freezers (-20°C and -70°C) for storing and managing your clinical trial samples. This integrated approach ensures the integrity of your IP and samples while reducing your logistical burden.
-
Project and Site Management
Our dedicated Clinical Project Managers (CPMs) are specialists in endocrinology research. With over 20 years of collective experience, our team ensures your study adheres to all protocol and quality standards. We maintain transparent communication and close coordination with clinical sites to ensure smooth progress and help you achieve your research goals.
-
Seamless Data Management and Statistical Analysis
Our team handles large, complex datasets from thousands of subjects, providing reliable and clean data for analysis. Equilab also involved in many vaccine studies to perform the statistical analysis and deliver the report to the Sponsor.
Overview
With a legacy of running more than 35+ global and regional trials, Equilab is your CRO partner in vaccine, immunology, and infectious disease research in Indonesia.
As one of the largest countries in the world, Indonesia offers a vast, treatment-naïve patient population and high disease prevalence, making it an ideal location for infectious disease and vaccine trials. This also includes a significant number of patients for rare diseases and neglected tropical diseases (NTDs).
We are experts in managing studies for both preventative vaccines and therapeutic drugs. Our extensive experience covers bacteriology, virology, and their associated diseases. We capitalize on this with our network of investigators and a team of project managers with over 20 years of experience, who have a proven track record of managing and ensuring trial success. We also proactively build site capacity to support complex clinical research in Indonesia, from adult to pediatric populations.
